This study uncovers a nonlinear relationship between serum albumin levels and cancer mortality risk, suggesting that the risk of mortality triggered by a decrease in albumin levels is ampl at lower levels of albumin, thus exhibiting threshold effects. This evidence concerns the gene ALB and cancer.